Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IAH0968 plus CAPEOX in HER2-positive metastatic colorectal cancer
CTR20223453Phase 2Active
- Sponsor
- SUNHO BioPharmaceutical
- Start
- May 2023
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of IAH0968 in colorectal cancer (CRC), sponsored by SUNHO BioPharmaceutical. Started May 2023; status: active.
02
Drugs
IAH0968
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on CTR20223453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20223453.